Researchers find multiple important biomarkers in people with Hikikomori (pathological social withdrawal), and they demonstrate their potential for predicting the severity of the disorder.
Key blood biomarkers for the pathological social withdrawal disorder called Hikikomori have been discovered by researchers at Kyushu University. The team’s research enabled them to distinguish between healthy people and hikikomori sufferers, as well as to gauge the severity of the disease.
Hikikomori is a condition in which people isolate themselves from society and family for a time longer than six months, according to the Ministry of Health, Labour, and Welfare of Japan. Hikikomori, also called “pathological social withdrawal,” is said to affect over a million individuals in Japan as of 2022. Although it has traditionally been thought of as a syndrome specific to the Japanese culture, evidence over the past few decades has shown that it is increasingly becoming a global phenomenon. Some fear that the COVID-19.
Comments are closed.